Cellebrite DI Ltd.
CLBT
$17.09
$0.482.89%
NASDAQ
06/30/2025 | 12/31/2024 | 06/30/2024 | 03/31/2024 | ||
---|---|---|---|---|---|
Revenue | 113.28M | 109.05M | 95.71M | 89.58M | |
Total Other Revenue | -- | -- | -- | -- | |
Total Revenue | 113.28M | 109.05M | 95.71M | 89.58M | |
Cost of Revenue | 17.68M | 17.62M | 16.26M | 13.26M | |
Gross Profit | 95.60M | 91.43M | 79.45M | 76.32M | |
SG&A Expenses | 50.47M | 50.10M | 43.27M | 43.87M | |
Depreciation & Amortization | -- | -- | -- | -- | |
Other Operating Expenses | -- | -- | -- | -- | |
Total Operating Expenses | 96.76M | 93.32M | 83.23M | 80.34M | |
Operating Income | 16.52M | 15.73M | 12.49M | 9.25M | |
Income Before Tax | 20.79M | 19.90M | -22.02M | -69.33M | |
Income Tax Expenses | 1.32M | 628.00K | 1.80M | 2.04M | |
Earnings from Continuing Operations | 19.48M | 19.27M | -23.81M | -71.37M | |
Earnings from Discontinued Operations | -- | -- | -- | -- | |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | |
Net Income | 19.48M | 19.27M | -23.81M | -71.37M | |
EBIT | 16.52M | 15.73M | 12.49M | 9.25M | |
EBITDA | 19.11M | 18.46M | 15.06M | 11.93M | |
EPS Basic | 0.08 | 0.08 | -0.12 | -0.36 | |
Normalized Basic EPS | 0.06 | 0.05 | -0.07 | -- | |
EPS Diluted | 0.08 | 0.08 | -0.12 | -0.36 | |
Normalized Diluted EPS | 0.06 | 0.05 | -0.07 | -- | |
Average Basic Shares Outstanding | 240.36M | 233.25M | 198.95M | 196.82M | |
Average Diluted Shares Outstanding | 248.98M | 247.35M | 198.95M | 196.82M | |
Dividend Per Share | -- | -- | -- | -- | |
Payout Ratio | -- | -- | -- | -- |